Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review

Citation

Caponnetto P & Polosa R (2020) Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review. Health Psychology Research, 8 (2), pp. 117-124. https://doi.org/10.4081/hpr.2020.9237

Abstract
This review focuses on smoking cessation treatments for people with schizophrenia spectrum disorders. It concludes with comments on the significance of the research and why it constitutes an original contribution. We searched PubMed (National Library of Medicine), and PsycINFO (Ovid) (2006-2020) for studies on schizophrenic disorder (schizophrenia or psychotic or psychosis or severe mental illness) and smoking cessation treatment (smoking cessation treatment or varenicline or tobacco cessation or reduction or bupropion or NRT or behavioral treatment or e-cigarette). Studies found evidence suggesting that pharmacotherapy combined with behavioural therapy for smoking cessation is effective amongst smokers with schizophrenia spectrum disorders, although more long-term research is required. This review summarised and critically reviewed also studies on vaping as a smoking cessation strategy for smokers with schizophrenia spectrum disorders and evidence suggests that they may effective as smoking cessation tool and may be less harmful alternatives to combustible cigarette smoking. Consequently, e-cigarettes could be considered as an applicable instrument for Tobacco Harm Reduction (THR) and smoking cessation. Overall, there are very few studies of e-cigarettes for smoking cessation in patients with schizophrenia and these studies are very small. They have promising results, but more research is needed.

Keywords
smoking cessation treatments; schizophrenia spectrum disorders; review

Journal
Health Psychology Research: Volume 8, Issue 2

• Accepted manuscript